CureVac N.V.
CVAC
$5.16
$0.050.98%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 896.67% | 626.78% | 81.95% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 896.67% | 626.78% | 81.95% |
| Cost of Revenue | -- | -- | -9.07% | 13.47% | 25.81% |
| Gross Profit | -- | -- | 789.22% | 308.90% | -1.82% |
| SG&A Expenses | -- | -- | -22.28% | -10.07% | -14.34% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -53.30% | 50.92% | 62.68% |
| Total Operating Expenses | -- | -- | 1.40% | 19.51% | 22.97% |
| Operating Income | -- | -- | 179.62% | 83.54% | -14.22% |
| Income Before Tax | -- | -- | 173.63% | 80.23% | 5.04% |
| Income Tax Expenses | -- | -- | 14,448.48% | 23,969.41% | 16,013.10% |
| Earnings from Continuing Operations | -- | -- | 162.53% | 74.92% | 4.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | 162.53% | 74.92% | 4.30% |
| EBIT | -- | -- | 179.62% | 83.54% | -14.22% |
| EBITDA | -- | -- | 191.89% | 88.83% | -16.33% |
| EPS Basic | -- | -- | 161.59% | 76.77% | 13.75% |
| Normalized Basic EPS | -- | -- | 216.40% | 84.67% | -33.24% |
| EPS Diluted | -- | -- | 161.23% | 76.56% | 13.75% |
| Normalized Diluted EPS | -- | -- | 216.75% | 85.01% | -32.91% |
| Average Basic Shares Outstanding | -- | -- | 1.59% | 5.40% | 9.71% |
| Average Diluted Shares Outstanding | -- | -- | 1.83% | 5.65% | 9.97% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |